Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis.

MLA

Kaltenhäuser, S., et al. “Antibodies against Cyclic Citrullinated Peptide Are Associated with the DRB1 Shared Epitope and Predict Joint Erosion in Rheumatoid Arthritis.” Rheumatology (Oxford, England), vol. 46, no. 1, Jan. 2007, pp. 100–04. EBSCOhost, https://doi.org/10.1093/rheumatology/kel052.

APA

Kaltenhäuser, S., Pierer, M., Arnold, S., Kamprad, M., Baerwald, C., Häntzschel, H., & Wagner, U. (2007). Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis. Rheumatology (Oxford, England), 46(1), 100–104. https://doi.org/10.1093/rheumatology/kel052

Chicago

Kaltenhäuser, S, M Pierer, S Arnold, M Kamprad, C Baerwald, H Häntzschel, and U Wagner. 2007. “Antibodies against Cyclic Citrullinated Peptide Are Associated with the DRB1 Shared Epitope and Predict Joint Erosion in Rheumatoid Arthritis.” Rheumatology (Oxford, England) 46 (1): 100–104. doi:10.1093/rheumatology/kel052.